Home NDC 63629-4688-5 Escitalopram
Product NDC 63629-4688
Requested package NDC 63629-4688-5
11-digit product format 636294688
Labeler code 63629
Product ID 63629-4688_2f8d7728-b2e0-4061-8118-9c58004a2bc4
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Escitalopram
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Bryant Ranch Prepack
Application ANDA076765
Marketing category ANDA
Marketing start 2012-03-14
Marketing end 0000-00-00
Substance ESCITALOPRAM OXALATE
Active strength 10 mg/1
Pharmacologic classes Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA]
NDC exclude flag No
Listing certified through 2021-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 14 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Code, Status table Captured / source date Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 D Discontinued by firm ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 D Discontinued by firm 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 D Discontinued by firm 557ba5c1ecfa…9c80585c8c6e…2020-12-18 03:04 UTC · source 2020-12-17 I Inactivated by FDA e2bbac7714bc…27bdfed8d636…2020-06-10 20:45 UTC · source 2020-06-10 I Inactivated by FDA 9bebd1f3094a…5416666fcb17…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A076765-001 ESCITALOPRAM OXALATE ESCITALOPRAM OXALATE EQ 5MG BASE TABLET / ORAL 2012-03-14 A076765-002 ESCITALOPRAM OXALATE ESCITALOPRAM OXALATE EQ 10MG BASE TABLET / ORAL 2012-03-14 A076765-003 ESCITALOPRAM OXALATE ESCITALOPRAM OXALATE EQ 20MG BASE TABLET / ORAL 2012-03-14
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 126 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A076765-001 ESCITALOPRAM OXALATE EQ 5MG BASE TABLET / ORAL 2012-03-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A076765-002 ESCITALOPRAM OXALATE EQ 10MG BASE TABLET / ORAL 2012-03-14 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A076765-003 ESCITALOPRAM OXALATE EQ 20MG BASE TABLET / ORAL 2012-03-14 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A076765-001 ESCITALOPRAM OXALATE EQ 5MG BASE TABLET / ORAL 2012-03-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076765-002 ESCITALOPRAM OXALATE EQ 10MG BASE TABLET / ORAL 2012-03-14 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A076765-003 ESCITALOPRAM OXALATE EQ 20MG BASE TABLET / ORAL 2012-03-14 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076765-001 ESCITALOPRAM OXALATE EQ 5MG BASE TABLET / ORAL 2012-03-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076765-002 ESCITALOPRAM OXALATE EQ 10MG BASE TABLET / ORAL 2012-03-14 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076765-003 ESCITALOPRAM OXALATE EQ 20MG BASE TABLET / ORAL 2012-03-14 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A076765-001 ESCITALOPRAM OXALATE EQ 5MG BASE TABLET / ORAL 2012-03-14 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076765-002 ESCITALOPRAM OXALATE EQ 10MG BASE TABLET / ORAL 2012-03-14 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A076765-003 ESCITALOPRAM OXALATE EQ 20MG BASE TABLET / ORAL 2012-03-14 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076765-001 ESCITALOPRAM OXALATE EQ 5MG BASE TABLET / ORAL 2012-03-14 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076765-002 ESCITALOPRAM OXALATE EQ 10MG BASE TABLET / ORAL 2012-03-14 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076765-003 ESCITALOPRAM OXALATE EQ 20MG BASE TABLET / ORAL 2012-03-14 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076765-001 ESCITALOPRAM OXALATE EQ 5MG BASE TABLET / ORAL 2012-03-14 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076765-002 ESCITALOPRAM OXALATE EQ 10MG BASE TABLET / ORAL 2012-03-14 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076765-003 ESCITALOPRAM OXALATE EQ 20MG BASE TABLET / ORAL 2012-03-14 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076765-001 ESCITALOPRAM OXALATE EQ 5MG BASE TABLET / ORAL 2012-03-14 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076765-002 ESCITALOPRAM OXALATE EQ 10MG BASE TABLET / ORAL 2012-03-14 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076765-003 ESCITALOPRAM OXALATE EQ 20MG BASE TABLET / ORAL 2012-03-14 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076765-001 ESCITALOPRAM OXALATE EQ 5MG BASE TABLET / ORAL 2012-03-14 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076765-002 ESCITALOPRAM OXALATE EQ 10MG BASE TABLET / ORAL 2012-03-14 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076765-003 ESCITALOPRAM OXALATE EQ 20MG BASE TABLET / ORAL 2012-03-14 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076765-001 ESCITALOPRAM OXALATE EQ 5MG BASE TABLET / ORAL 2012-03-14 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076765-002 ESCITALOPRAM OXALATE EQ 10MG BASE TABLET / ORAL 2012-03-14 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076765-003 ESCITALOPRAM OXALATE EQ 20MG BASE TABLET / ORAL 2012-03-14 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076765-001 ESCITALOPRAM OXALATE EQ 5MG BASE TABLET / ORAL 2012-03-14 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076765-002 ESCITALOPRAM OXALATE EQ 10MG BASE TABLET / ORAL 2012-03-14 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076765-003 ESCITALOPRAM OXALATE EQ 20MG BASE TABLET / ORAL 2012-03-14 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A076765-001 ESCITALOPRAM OXALATE EQ 5MG BASE TABLET / ORAL 2012-03-14 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A076765-002 ESCITALOPRAM OXALATE EQ 10MG BASE TABLET / ORAL 2012-03-14 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A076765-003 ESCITALOPRAM OXALATE EQ 20MG BASE TABLET / ORAL 2012-03-14 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A076765-001 ESCITALOPRAM OXALATE EQ 5MG BASE TABLET / ORAL 2012-03-14 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A076765-002 ESCITALOPRAM OXALATE EQ 10MG BASE TABLET / ORAL 2012-03-14 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A076765-003 ESCITALOPRAM OXALATE EQ 20MG BASE TABLET / ORAL 2012-03-14 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A076765-001 ESCITALOPRAM OXALATE EQ 5MG BASE TABLET / ORAL 2012-03-14 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A076765-002 ESCITALOPRAM OXALATE EQ 10MG BASE TABLET / ORAL 2012-03-14 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A076765-003 ESCITALOPRAM OXALATE EQ 20MG BASE TABLET / ORAL 2012-03-14 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A076765-001 ESCITALOPRAM OXALATE EQ 5MG BASE TABLET / ORAL 2012-03-14 1e350fbaab3a…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 51 observed states.
FDA-Initiated Inactive NDC Indexing# NDC, Effective, Related label table NDC Effective Related label 63629-4688-1 2020-12-28 These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002 63629-4688-2 2020-12-28 These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002 63629-4688-3 2020-12-28 These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002 63629-4688-4 2020-12-28 These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002 63629-4688-5 2020-12-28 These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002 63629-4688-6 2020-12-28 These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002 63629-4688-7 2020-12-28 These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002 63629-4688-1 2020-01-31 These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002 63629-4688-2 2020-01-31 These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002 63629-4688-3 2020-01-31 These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002 63629-4688-4 2020-01-31 These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002 63629-4688-5 2020-01-31 These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002 63629-4688-6 2020-01-31 These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002 63629-4688-7 2020-01-31 These highlights do not include all the information needed to use ESCITALOPRAM TABLETS safely and effectively. See full prescribing information for ESCITALOPRAM TABLETS. ESCITALOPRAM tablets, for oral use Initial U.S. Approval: 2002
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded ESCITALOPRAM OXALATE ACTIVE INGREDIENT 5U85DBW7LO ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK] 1001 ESCITALOPRAM ACTIVE MOIETY 4O4S742ANY ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK] 1001 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK] 1001 CROSCARMELLOSE SODIUM INACTIVE INGREDIENT M28OL1HH48 ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK] 1001 HYPROMELLOSE 2910 (15 MPA.S) INACTIVE INGREDIENT 36SFW2JZ0W ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK] 1001 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK] 1001 MANNITOL INACTIVE INGREDIENT 3OWL53L36A ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK] 1001 POLYETHYLENE GLYCOL 6000 INACTIVE INGREDIENT 30IQX730WE ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK] 1001 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK] 1001 TITANIUM DIOXIDE INACTIVE INGREDIENT 15FIX9V2JP ESCITALOPRAM TABLET, FILM COATED [BRYANT RANCH PREPACK] 1001
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 63629-4688-5 63629468805 10 TABLET, FILM COATED in 1 BOTTLE (63629-4688-5) 2012-03-29 0000-00-00 No No Current